Photo by nci from unsplash
Atypical haemolytic uraemic syndrome (aHUS) is a debilitating condition that can cause significant morbidity and mortality in children if not adequately and promptly treated. This report shares real‐world data on… Click to show full abstract
Atypical haemolytic uraemic syndrome (aHUS) is a debilitating condition that can cause significant morbidity and mortality in children if not adequately and promptly treated. This report shares real‐world data on the use of eculizumab in children with aHUS.
Keywords:
uraemic syndrome;
atypical haemolytic;
paediatric atypical;
eculizumab paediatric;
haemolytic uraemic
Journal Title: Journal of Paediatrics and Child Health
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Paediatrics and Child Health
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!